{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T09:44:30Z","timestamp":1753868670796,"version":"3.41.2"},"reference-count":31,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Reports"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Acyclovir treatment is an efficient prophylaxis to prevent varicella\u2010zoster virus (VZV) reactivation after allogeneic hematopoietic stem cell transplantation (HSCT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>This single center retrospective study tried to determine if the lymphocytes immunophenotyping could help to determine the duration of prophylaxis, and evaluated complications, and associated risk factors for VZV infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and Results<\/jats:title><jats:p>Eighty\u2010four children underwent an allogeneic HSCT, in which 77 received an acyclovir prophylaxis. Twenty\u2010one of the 77 had a VZV infection with an incidence rate of 1.30 per 100 patients\u2010months (exact 95% CI, 0.81 to 2.01). Among these 21 patients with VZV infection, 16 had an infection after withdrawing acyclovir prophylaxis within a median of 49\u2009days (range, 11\u2009days\u20135.8\u2009months). Thirty\u2010five percent of the VZV infected patients were hospitalized, 9% had a visceral dissemination, and 9% had postherpetic neuralgia. In multivariate analysis, higher VZV infection rate was associated with conditioning regimen with total body irradiation, immunoglobulin substitution, and antithymocyte globulin. The incidence of VZV infection increased significantly when patients had a CD4+ lymphocytes count below 23% (cHR 3.28 [95% CI, 1.09\u20139.81]; <jats:italic>p<\/jats:italic>\u2009=\u20090.03) or a CD4<jats:sup>+<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup> ratio less than 0.9 (cHR 3.13 [95% CI, 1.04\u20139.36]; <jats:italic>p<\/jats:italic>\u2009=\u20090.04) at the time of stopping acyclovir prophylaxis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>After cessation of acyclovir prophylaxis, VZV reactivation can occur and be responsible for morbidity after allogeneic HSCT. This study suggests that the proportion of CD4+ lymphocytes and the CD4<jats:sup>+<\/jats:sup>\/CD8<jats:sup>+<\/jats:sup> ratio can inform decisions about the duration of acyclovir prophylaxis after allogeneic HSCT to prevent VZV reactivation.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cnr2.70015","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:46:04Z","timestamp":1730983564000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["<scp>VZV<\/scp> Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?"],"prefix":"10.1002","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8866-2831","authenticated-orcid":false,"given":"Eva","family":"de Berranger","sequence":"first","affiliation":[{"name":"Paediatric Hematology  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne\u2010Flore","family":"Derache","sequence":"additional","affiliation":[{"name":"Paediatric Hematology  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nassima","family":"Ramdane","sequence":"additional","affiliation":[{"name":"Department of Biostatistics  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Labreuche","sequence":"additional","affiliation":[{"name":"Department of Biostatistics  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Navarin","sequence":"additional","affiliation":[{"name":"Paediatric Hematology  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Gonzales","sequence":"additional","affiliation":[{"name":"Paediatric Hematology  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wadih","family":"Abou\u2010Chahla","sequence":"additional","affiliation":[{"name":"Paediatric Hematology  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1048-1517","authenticated-orcid":false,"given":"Brigitte","family":"Nelken","sequence":"additional","affiliation":[{"name":"Paediatric Hematology  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9n\u00e9dicte","family":"Bruno","sequence":"additional","affiliation":[{"name":"Paediatric Hematology  Lille France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705191"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12073"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70280-9"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1083-8791(00)70051-6"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702119"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12180"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006546"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29979"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2007.00247.x"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2010.00541.x"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14201"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13061"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.705179"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2008.386"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2005.09.004"},{"issue":"6","key":"e_1_2_10_17_1","first-page":"825","article-title":"1994 Consensus Conference on Acute GVHD Grading","volume":"15","author":"Przepiorka D.","year":"1995","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.06.002"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-077644"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2013.09.020"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704959"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-09-3624"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701796"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2013.03.014"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.052"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702190"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002367"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00507"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0064"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.02.001"},{"issue":"2","key":"e_1_2_10_31_1","first-page":"219","article-title":"Regeneration of Immunity and Varicella\u2010Zoster Virus Infection After High\u2010Dose Chemotherapy and Peripheral Blood Stem Cell Autografts in Children","volume":"14","author":"Takaue Y.","year":"1994","journal-title":"Bone Marrow Transplantation"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268810003031"}],"container-title":["Cancer Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cnr2.70015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T03:25:44Z","timestamp":1732677944000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cnr2.70015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1002\/cnr2.70015"],"URL":"https:\/\/doi.org\/10.1002\/cnr2.70015","archive":["Portico"],"relation":{},"ISSN":["2573-8348","2573-8348"],"issn-type":[{"type":"print","value":"2573-8348"},{"type":"electronic","value":"2573-8348"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"2024-01-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70015"}}